| 2241P A novel 89Zr-anti-PD-1 immuno-PET-CT may predict response to PD-1 inhibitors and improve response assessment in a lung cancer murine model receiving immunotherapy A Puyalto, M Rodríguez-Remírez, I López, JA Simon, M Ecay, M Collantes, ... Annals of Oncology 34, S1154-S1155, 2023 | | 2023 |
| 962 Integrative immunomics highlight the immunomodulatory impact of neoadjuvant chemotherapy and immune-based treatments in resected non-small-cell lung cancer S Schmidt, Y Lee, C Leung, L Federico, H Lin, A Weissferdt, A Pataer, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | | 2021 |
| A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer A Puyalto, M Rodríguez-Remírez, I López, F Iribarren, JA Simón, M Ecay, ... Frontiers in Immunology 14, 1272570, 2023 | 1 | 2023 |
| A novel 89Zr-a-PD-1 immuno-PET-CT may improve pseudoprogression detection in a lung cancer murine model receiving immunotherapy. A Puyalto Calvo, M Rodríguez-Remírez, I Lopez, F Iribarren, M Torregrosa, ... Journal of Clinical Oncology 41 (16_suppl), e15116-e15116, 2023 | | 2023 |
| Abstract CT111: Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa LR Uribe, W Wu, O Gelincik, PV Bommi, A Francisco-Cruz, LM Solis, ... Cancer Research 80 (16_Supplement), CT111-CT111, 2020 | | 2020 |
| Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non–Small Cell Lung Cancer A Francisco-Cruz, P Rocha, A Reuben, SN Krishnan, P Das, R Chen, ... Modern Pathology 36 (1), 100028, 2023 | 4 | 2023 |
| Author Correction: Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis Y Wang, DH Wiesnoski, BA Helmink, V Gopalakrishnan, K Choi, ... Nature medicine 25 (1), 188-188, 2019 | 14 | 2019 |
| Circulating antigens in mice infected with Mycobacterium tuberculosis and in patients with tuberculosis BP Ruiz-Sánchez, A Francisco-Cruz, S Miguel-Hernández, ... Revista médica del Hospital General de México 83 (3), 104-112, 2020 | 2 | 2020 |
| Design of multiplex immunofluorescence panel with immune contexture markers of nodular sclerosis classical Hodgkin lymphoma JL Solorzano, A Francisco-Cruz, A Martin-Moreno, RS Alejo, ER Parra, ... LABORATORY INVESTIGATION 98, 555-556, 2018 | | 2018 |
| Efficacy of gene-therapy based on adenovirus encoding granulocyte-macrophage colony-stimulating factor in drug-sensitive and drug-resistant experimental pulmonary tuberculosis A Francisco-Cruz, D Mata-Espinosa, O Ramos-Espinosa, ... Tuberculosis 100, 5-14, 2016 | 18 | 2016 |
| Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis Y Wang, DH Wiesnoski, BA Helmink, V Gopalakrishnan, K Choi, ... Nature medicine 24 (12), 1804-1808, 2018 | 583 | 2018 |
| Gene therapy based in antimicrobial peptides and proinflammatory cytokine prevents reactivation of experimental latent tuberculosis O Ramos-Espinosa, S Hernà ¡ ndez-Bazà ¡ n, A Francisco-Cruz, ... FEMS Pathogens and Disease 74 (7), ftw075, 2016 | 19 | 2016 |
| Granulocyte–macrophage colony-stimulating factor: not just another haematopoietic growth factor A Francisco-Cruz, M Aguilar-Santelises, O Ramos-Espinosa, ... Medical oncology 31, 1-14, 2014 | 200 | 2014 |
| Immuno-oncology panel optimization for imaging mass cytometry and digital image analysis of tumor tissues P Rocha, L Solis, E Parra, O Shi, B Mino, VC Sinha, A Rinkenbaugh, ... Cancer Research 80 (16_Supplement), 2679-2679, 2020 | | 2020 |
| Immunogenicity and protection conferred by Mycobacterium habana in a murine model of pulmonary tuberculosis I Valdés, E Montoro, D Mata-Espinoza, O Asín, J Barrios-Payan, ... Tuberculosis 94 (1), 65-72, 2014 | 16 | 2014 |
| Immunotherapeutic effect of adenovirus encoding antimicrobial peptides in experimental pulmonary tuberculosis O Ramos-Espinosa, D Mata-Espinosa, A Francisco-Cruz, ... Journal of Leukocyte Biology 110 (5), 951-963, 2021 | 5 | 2021 |
| Immunotherapeutic effects of recombinant adenovirus encoding granulocyte–macrophage colony-stimulating factor in experimental pulmonary tuberculosis A Francisco-Cruz, D Mata-Espinosa, S Estrada-Parra, Z Xing, ... Clinical & Experimental Immunology 171 (3), 283-297, 2013 | 36 | 2013 |
| Immunotherapeutic effects of recombinant adenovirus encoding interleukin 12 in experimental pulmonary tuberculosis DA Mata‐Espinosa, A Francisco‐Cruz, B Marquina‐Castillo, ... Scandinavian journal of immunology 89 (3), e12743, 2019 | 15 | 2019 |
| Impact of the spatial analysis of tumor-associated lymphocytes and tumor-associated macrophages on recurrence at early stage of non-small cell lung carcinoma A Francisco-Cruz, ER Parra, SN Krishnan, S Barua, M Jiang, J Fujimoto, ... Cancer Research 79 (13_Supplement), 1180-1180, 2019 | | 2019 |
| Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity Y Hailemichael, DH Johnson, N Abdel-Wahab, WC Foo, SE Bentebibel, ... Cancer Cell 40 (5), 509-523. e6, 2022 | 142 | 2022 |
